|
1.
|
Hirohashi and Kanai Y: Cell adhesion
system and human cancer morphogenesis. Cancer Sci. 94:575–581.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
González-Mariscal L, Betanzos A, Nava P
and Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol.
81:1–44. 2003.
|
|
3.
|
Morita K, Furuse M, Fujimoto K and Tsukita
S: Claudin multigene family encoding four-transmembrane domain
protein components of tight junction strands. Proc Natl Acad Sci
USA. 96:511–516. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Kominsky SL, Argani P, Korz D, Evron E,
Raman V, Garrett E, Rein A, Sauter G, et al: Loss of the tight
junction protein claudin-7 correlates with histological grade in
both ductal carcinoma in situ and invasive ductal carcinoma of the
breast. Oncogene. 22:2021–2033. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Al Moustafa AE, Alaoui-Jamali MA, Batist
G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R and
Foulkes WD: Identification of genes associated with head and neck
carcinogenesis by cDNA microarray comparison between matched
primary normal epithelial and squamous carcinoma cells. Oncogene.
21:2634–2640. 2002.
|
|
6.
|
Amant F, Moerman P, Neven P, Timmerman D,
Van Limbergen E and Vergote I: Endometrial cancer. Lancet.
366:491–505. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
American Cancer Society: Cancer Facts
& Figures 2011. American Cancer Society; Atlanta: 2011
|
|
8.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
9.
|
Dedes KJ, Wetterskog D, Ashworth A, Kaye
SB and Reis-Filho JS: Emerging therapeutic targets in endometrial
cancer. Nat Rev Clin Oncol. 8:261–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Pan XY, Wang B, Che YC, Weng ZP, Dai HY
and Peng W: Expression of claudin-3 and claudin-4 in normal,
hyperplastic, and malignant endometrial tissue. Int J Gynecol
Cancer. 17:233–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Santin AD, Zhan F, Cane’ S, Bellone S,
Palmieri M, Thomas M, et al: Gene expression fingerprint of uterine
serous papillary carcinoma: identification of novel molecular
markers for uterine serous cancer diagnosis and therapy. Br J
Cancer. 92:1561–1573. 2005. View Article : Google Scholar
|
|
12.
|
Moldvay J, Jäckel M, Páska C, Soltész I,
Schaff Z and Kiss A: Distinct claudin expression profile in
histologic subtypes of lung cancer. Lung Cancer. 57:159–167. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Swisshelm K, Macek R and Kubbies M: Role
of claudins in tumorigenesis. Adv Drug Deliv Rev. 57:919–928. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lioni M, Brafford P, Andl C, Rustgi A,
El-Deiry W, Herlyn M and Smalley KS: Dysregulation of claudin-7
leads to loss of E-cadherin expression and the increased invasion
of esophageal squamous cell carcinoma cells. Am J Pathol.
170:709–721. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Lu Z, Ding L, Hong H, Hoggard J, Lu Q and
Chen YH: Claudin-7 inhibits human lung cancer cell migration and
invasion through ERK/MAPK signaling pathway. Exp Cell Res.
317:1935–1946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Murata M, Kojima T, Yamamoto T, Go M,
Takano K, Osanai M, Chiba H and Sawada N: Down-regulation of
survival signaling through MAPK and Akt in occludin-deficient mouse
hepatocytes in vitro. Exp Cell Res. 310:140–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
